Literature DB >> 16098363

Quality of life after radical treatment of prostate cancer: validation of the Italian version of the University of California-Los Angeles Prostate Cancer Index.

M Gacci1, L Livi, F Paiar, B Detti, M S Litwin, R Bartoletti, G Giubilei, T Cai, M Mariani, M Carini.   

Abstract

OBJECTIVES: To validate an Italian version of the University of California-Los Angeles Prostate Cancer Index (UCLA-PCI).
METHODS: Men with prostate cancer treated with radical retropubic prostatectomy (RRP) or external beam radiation (EBR) were retrospectively selected. Each subject was asked to complete the UCLA-PCI short form and the 36-item short-form health survey (SF-36) questionnaires (principal sample); a subgroup completed both questionnaires twice (retest sample). A linguistic translation and validation was performed. Psychometric properties were analyzed.
RESULTS: A total of 595 men were included in the study: 394 from the Department of Urology (treated with RRP) and 201 from the Department of Radiotherapy (treated with EBR). Of these, 75 patients (50 from the RRP group and 25 from the EBR group) were selected as the retest cohort. Internal consistency reliability of the SF-36 and UCLA-PCI for the primary sample of the surgery and radiotherapy populations ranged from 0.82 to 0.94; the mean values of sexual function were superior in the principal urology group, whereas the principal radiotherapy group demonstrated superior mean values of urinary function and urinary bother. A strong correlation between urinary function and sexual and bowel function, and between urinary function and all bother scales, was reported only for patients treated with RRP. The expected correlation between sexual function and sexual bother was reported for the EBR group but not for the RRP group.
CONCLUSIONS: Our study demonstrated the excellent psychometric properties of the Italian version of the UCLA-PCI; the Italian version of the UCLA-PCI questionnaire will allow cross-cultural comparative studies in men with prostate cancer.

Entities:  

Mesh:

Year:  2005        PMID: 16098363     DOI: 10.1016/j.urology.2005.02.027

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  9 in total

Review 1.  Quality-of-life assessment tools for men with prostate cancer.

Authors:  Jonathan Bergman; Aaron Laviana
Journal:  Nat Rev Urol       Date:  2014-05-20       Impact factor: 14.432

Review 2.  The effect of ethnicity and sexual preference on prostate-cancer-related quality of life.

Authors:  Nir Kleinmann; Nicholas G Zaorsky; Timothy N Showalter; Leonard G Gomella; Costas D Lallas; Edouard J Trabulsi
Journal:  Nat Rev Urol       Date:  2012-04-10       Impact factor: 14.432

3.  Influence of serum testosterone on urinary continence and sexual activity in patients undergoing radical prostatectomy for clinically localized prostate cancer.

Authors:  M Gacci; G Corona; G Apolone; A Apolone; M Lanciotti; N Tosi; S Giancane; L Masieri; S Serni; M Maggi; M Carini
Journal:  Prostate Cancer Prostatic Dis       Date:  2010-03-09       Impact factor: 5.554

4.  How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study.

Authors:  Mauro Gacci; Walter Artibani; Pierfrancesco Bassi; Filippo Bertoni; Sergio Bracarda; Alberto Briganti; Giorgio Carmignani; Luca Carmignani; Giario Conti; Renzo Corvò; Cosimo De Nunzio; Ferdinando Fusco; Pierpaolo Graziotti; Isabella Greco; Stefania Maggi; Stefano Maria Magrini; Vincenzo Mirone; Rodolfo Montironi; Giuseppe Morgia; Giovanni Muto; Marianna Noale; Stefano Pecoraro; Angelo Porreca; Umberto Ricardi; Elvio Russi; Giorgio Russo; Andrea Salonia; Alchiede Simonato; Sergio Serni; Davide Tomasini; Andrea Tubaro; Vittorina Zagonel; Gaetano Crepaldi
Journal:  World J Urol       Date:  2020-08-01       Impact factor: 4.226

5.  Assessing quality of life in patients with prostate cancer: a systematic and standardized comparison of available instruments.

Authors:  Stefanie Schmidt; Olatz Garin; Yolanda Pardo; José M Valderas; Jordi Alonso; Pablo Rebollo; Luis Rajmil; Carlos Garcia-Forero; Montse Ferrer
Journal:  Qual Life Res       Date:  2014-04-19       Impact factor: 4.147

6.  Urinary and sexual outcomes in long-term (5+ years) prostate cancer disease free survivors after radical prostatectomy.

Authors:  Mauro Gacci; Alchiede Simonato; Lorenzo Masieri; John L Gore; Michele Lanciotti; Annalisa Mantella; Mario Alberto Rossetti; Sergio Serni; Virginia Varca; Andrea Romagnoli; Carlo Ambruosi; Fabio Venzano; Marco Esposito; Tomaso Montanaro; Giorgio Carmignani; Marco Carini
Journal:  Health Qual Life Outcomes       Date:  2009-11-13       Impact factor: 3.186

Review 7.  Quality of Life and Sexual Health in the Aging of PCa Survivors.

Authors:  Mauro Gacci; Elisabetta Baldi; Lara Tamburrino; Beatrice Detti; Lorenzo Livi; Cosimo De Nunzio; Andrea Tubaro; Stavros Gravas; Marco Carini; Sergio Serni
Journal:  Int J Endocrinol       Date:  2014-03-17       Impact factor: 3.257

8.  Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study.

Authors:  Angelo Porreca; Marianna Noale; Walter Artibani; Pier Francesco Bassi; Filippo Bertoni; Sergio Bracarda; Giario Natale Conti; Renzo Corvò; Mauro Gacci; Pierpaolo Graziotti; Stefano Maria Magrini; Vincenzo Mirone; Rodolfo Montironi; Giovanni Muto; Stefano Pecoraro; Umberto Ricardi; Elvio Russi; Andrea Tubaro; Vittorina Zagonel; Gaetano Crepaldi; Stefania Maggi
Journal:  Health Qual Life Outcomes       Date:  2018-06-13       Impact factor: 3.186

9.  Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR).

Authors:  Michela Buglione; Marianna Noale; Alessio Bruni; Alessandro Antonelli; Filippo Bertoni; Renzo Corvo'; Umberto Ricardi; Paolo Borghetti; Marta Maddalo; Claudio Simeone; Ercole Mazzeo; Angelo Porreca; Sergio Serni; Pierfrancesco Bassi; Mauro Gacci; Vincenzo Mirone; Rodolfo Montironi; Andrea Tubaro; Alfredo Berruti; Giario Natale Conti; Stefania Maggi; Stefano Maria Magrini; Luca Triggiani
Journal:  PLoS One       Date:  2019-11-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.